BROWN GREGORY B

Director at OSCIENT PHARMACEUTICALS CORP · on record since Aug 22, 2006
10% owner at OSCIENT PHARMACEUTICALS CORP · on record since Aug 22, 2006
Director at Aquestive Therapeutics, Inc. · on record since Jun 12, 2026
Director at PHASE III MEDICAL INC/DE · on record since Oct 12, 2016
Director at Invuity, Inc. · on record since Jun 11, 2015
Director at CAMBREX CORP · on record since Nov 2, 2017

Insider trading activity of BROWN GREGORY B

Transactions on record: 43; since Aug 22, 2006

Open-market buys: 0

Open-market sells: 1; $540.9K

Companies traded: 4; last filing Jun 12, 2026

Figures computed from official regulatory filings — methodology.

Companies where BROWN GREGORY B has traded

Aquestive Therapeutics, Inc.9 tx · $143.2K · Jun 12, 2026
PHASE III MEDICAL INC/DE15 tx · $120K · Jan 13, 2026
CAMBREX CORP13 tx · $774K · Dec 5, 2019
OSCIENT PHARMACEUTICALS CORP6 tx · Jun 13, 2008

Track record of BROWN GREGORY B

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of BROWN GREGORY B

Co-insiders of BROWN GREGORY B

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Aquestive Therapeutics, Inc.	Jun 12, 2026	AwardD	50,500	0.00 USD	$0	SEC
PHASE III MEDICAL INC/DE	Jan 13, 2026	Award	30,456	0.00 USD	$0	SEC
Aquestive Therapeutics, Inc.	Jun 12, 2025	AwardD	42,000	3.41 USD	$143.2K	SEC
PHASE III MEDICAL INC/DE	Jan 13, 2025	Award	15,789	0.00 USD	$0	SEC
Aquestive Therapeutics, Inc.	Jun 21, 2024	AwardD	38,000	0.00 USD	$0	SEC
PHASE III MEDICAL INC/DE	Jan 11, 2024	Award	19,480	0.00 USD	$0	SEC
Aquestive Therapeutics, Inc.	Jun 23, 2023	AwardD	25,000	0.00 USD	$0	SEC
PHASE III MEDICAL INC/DE	Jan 11, 2023	Award	20,000	0.00 USD	$0	SEC
Aquestive Therapeutics, Inc.	Jun 24, 2022	AwardD	25,000	0.00 USD	$0	SEC
PHASE III MEDICAL INC/DE	Jan 12, 2022	Award	65,430	0.00 USD	$0	SEC
Aquestive Therapeutics, Inc.	Jun 21, 2021	AwardD	20,000	0.00 USD	$0	SEC
PHASE III MEDICAL INC/DE	Jan 12, 2021	Award	37,735	0.00 USD	$0	SEC
Aquestive Therapeutics, Inc.	Jun 18, 2020	AwardD	14,000	0.00 USD	$0	SEC
PHASE III MEDICAL INC/DE	Jan 14, 2020	Award	18,292	3.28 USD	$60K	SEC
CAMBREX CORP	Dec 5, 2019	Exercise	360	44.23 USD	$15.9K	SEC
CAMBREX CORP	Dec 5, 2019	Exercise	1,980	53.70 USD	$106.3K	SEC
CAMBREX CORP	Dec 5, 2019	ExerciseD	2,766	0.00 USD	$0	SEC
CAMBREX CORP	Dec 5, 2019	ExerciseD	1,980	0.00 USD	$0	SEC
CAMBREX CORP	Dec 5, 2019	Sell	-9,015	60.00 USD	$540.9K	SEC
CAMBREX CORP	Dec 5, 2019	ExerciseD	360	0.00 USD	$0	SEC
CAMBREX CORP	Dec 5, 2019	Exercise	2,766	40.06 USD	$110.8K	SEC
Aquestive Therapeutics, Inc.	Jun 17, 2019	AwardD	13,350	0.00 USD	$0	SEC
CAMBREX CORP	Apr 25, 2019	AwardD	2,766	0.00 USD	$0	SEC
CAMBREX CORP	Apr 25, 2019	Award	2,247	0.00 USD	$0	SEC
PHASE III MEDICAL INC/DE	Jan 16, 2019	Award	12,121	4.95 USD	$60K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Aquestive Therapeutics, Inc.	Jun 12, 2026	AwardD	50,500	0.00 USD	$0	SEC
PHASE III MEDICAL INC/DE	Jan 13, 2026	Award	30,456	0.00 USD	$0	SEC
Aquestive Therapeutics, Inc.	Jun 12, 2025	AwardD	42,000	3.41 USD	$143.2K	SEC
PHASE III MEDICAL INC/DE	Jan 13, 2025	Award	15,789	0.00 USD	$0	SEC
Aquestive Therapeutics, Inc.	Jun 21, 2024	AwardD	38,000	0.00 USD	$0	SEC
PHASE III MEDICAL INC/DE	Jan 11, 2024	Award	19,480	0.00 USD	$0	SEC
Aquestive Therapeutics, Inc.	Jun 23, 2023	AwardD	25,000	0.00 USD	$0	SEC
PHASE III MEDICAL INC/DE	Jan 11, 2023	Award	20,000	0.00 USD	$0	SEC
Aquestive Therapeutics, Inc.	Jun 24, 2022	AwardD	25,000	0.00 USD	$0	SEC
PHASE III MEDICAL INC/DE	Jan 12, 2022	Award	65,430	0.00 USD	$0	SEC
Aquestive Therapeutics, Inc.	Jun 21, 2021	AwardD	20,000	0.00 USD	$0	SEC
PHASE III MEDICAL INC/DE	Jan 12, 2021	Award	37,735	0.00 USD	$0	SEC
Aquestive Therapeutics, Inc.	Jun 18, 2020	AwardD	14,000	0.00 USD	$0	SEC
PHASE III MEDICAL INC/DE	Jan 14, 2020	Award	18,292	3.28 USD	$60K	SEC
CAMBREX CORP	Dec 5, 2019	Exercise	360	44.23 USD	$15.9K	SEC
CAMBREX CORP	Dec 5, 2019	Exercise	1,980	53.70 USD	$106.3K	SEC
CAMBREX CORP	Dec 5, 2019	ExerciseD	2,766	0.00 USD	$0	SEC
CAMBREX CORP	Dec 5, 2019	ExerciseD	1,980	0.00 USD	$0	SEC
CAMBREX CORP	Dec 5, 2019	Sell	-9,015	60.00 USD	$540.9K	SEC
CAMBREX CORP	Dec 5, 2019	ExerciseD	360	0.00 USD	$0	SEC
CAMBREX CORP	Dec 5, 2019	Exercise	2,766	40.06 USD	$110.8K	SEC
Aquestive Therapeutics, Inc.	Jun 17, 2019	AwardD	13,350	0.00 USD	$0	SEC
CAMBREX CORP	Apr 25, 2019	AwardD	2,766	0.00 USD	$0	SEC
CAMBREX CORP	Apr 25, 2019	Award	2,247	0.00 USD	$0	SEC
PHASE III MEDICAL INC/DE	Jan 16, 2019	Award	12,121	4.95 USD	$60K	SEC